Literature DB >> 8658068

Activation of phagocytes by Helicobacter pylori correlates with the clinical presentation of the gastric infection.

H Nielsen1, L P Andersen.   

Abstract

Only a minority of subjects with Helicobacter pylori infection develop clinical gastroduodenal disease. It is unclear whether host factors or bacterial virulence properties contribute to the pathogenic mechanisms. We have previously demonstrated a 25-35-kDa protein with phagocyte stimulatory activity in bacterial sonicates. Protein preparations were made from 15 H. neutrophil and monocyte chemotaxis and chemiluminescence was assessed with cells from healthy donors in comparison with N-f-methionyl-leucyl-phenylalanine and C5a anaphylatoxin. The potency of bacterial protein(s) for induction of monocyte chemiluminescence was significantly higher for strains from ulcer patients (1 +/- 1 microgram/ml induced > or = twofold increase of control response) and chronic active gastritis (1 +/- 1 microgram/ml) compared with superficial gastritis (> 1,000 microgram/ml, p<0.05). Neutrophil activation was also significantly more potent with strains from duodenal ulcer disease. The chemotactic activity of bacterial preparations was not significantly different between the groups. We conclude that bacterial strains with pronounced activation of phagocytes are associated with the presence of clinical ulcer disease, supporting the existence of ulcerogenic strains.

Entities:  

Mesh:

Year:  1995        PMID: 8658068     DOI: 10.3109/00365549509032729

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN: 0036-5548


  4 in total

Review 1.  Naturally acquired human immune responses against Helicobacter pylori and implications for vaccine development.

Authors:  Y Zevering; L Jacob; T F Meyer
Journal:  Gut       Date:  1999-09       Impact factor: 23.059

2.  Cloning and characterization of a novel membrane-associated antigenic protein of Helicobacter pylori.

Authors:  M Yoshida; Y Wakatsuki; Y Kobayashi; T Itoh; K Murakami; A Mizoguchi; T Usui; T Chiba; T Kita
Journal:  Infect Immun       Date:  1999-01       Impact factor: 3.441

3.  Genotypic and phenotypic stability of Helicobacter pylori markers in a nine-year follow-up study of patients with noneradicated infection.

Authors:  Anders Gustavsson; Magnus Unemo; Björn Blomberg; Dan Danielsson
Journal:  Dig Dis Sci       Date:  2005-02       Impact factor: 3.199

4.  Eradication of Helicobacter pylori restores glutathione S-transferase activity and glutathione levels in antral mucosa.

Authors:  A H Oijen; M L Verhulst; H M Roelofs; W H Peters; W A de Boer; J B Jansen
Journal:  Jpn J Cancer Res       Date:  2001-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.